Orexigen Therapeutics, Inc. News Headlines

Get OREX Alerts
*Delayed - data as of Feb. 26, 2015  -  Find a broker to begin trading OREX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    OREX Pre-Market
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
Orexigen Scripts Continue Impressive Track
1/21/2015 2:00:00 PM - Seeking Alpha

News Flash: The Endocrine Society Recommends Weight Loss Medications
1/21/2015 11:15:00 AM - Seeking Alpha

Orexigen Therapeutics, Inc. (OREX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/16/2015 7:00:00 AM - Investopedia

A Deeper Look At Arena's Belviq Pricing
1/12/2015 3:02:00 PM - Seeking Alpha

Orexigen's Contrave May Have Pricing Competition
1/12/2015 9:13:00 AM - Seeking Alpha

Sales Of Arena's Belviq Close Out 2014 - What Will 2015 Bring?
1/9/2015 2:49:00 PM - Seeking Alpha

Arena Investors Should Watch New Pricing Of Belviq Closely
1/9/2015 12:20:00 PM - Seeking Alpha

Anticipated FDA Approval Eludes Enteromedics
1/5/2015 12:21:00 PM - Seeking Alpha

Sell EnteroMedics And Step To The Sidelines
12/30/2014 12:25:00 PM - Seeking Alpha

Can High Priced Novo Nordisk Anti-Obesity Injection Make It?
12/29/2014 1:30:00 PM - Seeking Alpha

The Obesity Treatment Market Could Finally Achieve Some Of Its Potential In 2015
12/29/2014 1:24:00 PM - Seeking Alpha

Arena - Belviq Advertsing Closes Out Year With Big Push
12/29/2014 1:13:00 PM - Seeking Alpha

Is Vivus Headed Towards An Unfortunate Ending?
12/27/2014 8:27:00 AM - Seeking Alpha

4 Biotech Stocks that Doubled in 2014 - Analyst Blog
12/26/2014 9:00:00 AM - Investopedia

Novo Nordisk Enters Anti-Obesity Space With New FDA Approval
12/24/2014 7:46:00 AM - Seeking Alpha

Novo Nordisk's Saxenda Gets FDA Nod, Launch in 1H15 - Analyst Blog
12/24/2014 4:20:00 AM - Investopedia

Contrave Prescriptions Still Rising In A Down Week
12/22/2014 3:47:00 PM - Seeking Alpha

Orexigen - Contrave Script Numbers Remain Impressive
12/22/2014 3:31:00 PM - Seeking Alpha

Belviq Scripts Dip - Lack Of T.V. Ads Will Impact Next Numbers
12/22/2014 3:27:00 PM - Seeking Alpha

Orexigen Retreats After Positive News In Europe: 3 Things To Watch For
12/22/2014 3:18:00 PM - Seeking Alpha

Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog
12/22/2014 6:10:00 AM - Investopedia

JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice
12/21/2014 11:36:00 PM - RTT News

Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha

Arena And Vivus Investors Need To Grasp Implications Of Orexigen
12/19/2014 2:22:00 PM - Seeking Alpha

Contrave Wins Approval Recommendation In Europe
12/19/2014 11:53:00 AM - Seeking Alpha